Cargando…

Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries

BACKGROUND: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous condition. Recent studies suggest that MINOCA patients may have a proinflammatory disposition. The role of inflammation in MINOCA may thus be distinct to myocardial infarction with significant coronar...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggers, Kai M, Baron, Tomasz, Hjort, Marcus, Nordenskjöld, Anna M, Tornvall, Per, Lindahl, Bertil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259160/
https://www.ncbi.nlm.nih.gov/pubmed/34032303
http://dx.doi.org/10.1002/clc.23651
_version_ 1783718628917510144
author Eggers, Kai M
Baron, Tomasz
Hjort, Marcus
Nordenskjöld, Anna M
Tornvall, Per
Lindahl, Bertil
author_facet Eggers, Kai M
Baron, Tomasz
Hjort, Marcus
Nordenskjöld, Anna M
Tornvall, Per
Lindahl, Bertil
author_sort Eggers, Kai M
collection PubMed
description BACKGROUND: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous condition. Recent studies suggest that MINOCA patients may have a proinflammatory disposition. The role of inflammation in MINOCA may thus be distinct to myocardial infarction with significant coronary artery disease (MI‐CAD). HYPOTHESIS: We hypothesized that inflammation reflected by C‐reactive protein (CRP) levels might carry unique clinical information in MINOCA. METHODS: This retrospective registry‐based cohort study (SWEDEHEART) included 9916 patients with MINOCA and 97 970 MI‐CAD patients, used for comparisons. Multivariable‐adjusted regressions were applied to investigate the associations of CRP levels with clinical variables, all‐cause mortality and major cardiovascular events (MACE) during a median follow‐up of up to 5.3 years. RESULTS: Median admission CRP levels in patients with MINOCA and MI‐CAD were 5.0 (interquartile range 2.0–9.0) mg/dl and 5.0 (interquartile range 2.1–10.0 mg/dl), respectively. CRP levels in MINOCA exhibited independent associations with various cardiovascular risk factors, comorbidities and estimates of myocardial damage. The association of CRP with peripheral artery disease tended to be stronger compared to MI‐CAD. The associations with female sex, renal dysfunction and myocardial damage were stronger in MI‐CAD. CRP independently predicted all‐cause mortality in MINOCA (hazard ratio 1.22 [95% confidence interval 1.17–1.26]), similar to MI‐CAD (p interaction = 0.904). CRP also predicted MACE (hazard ratio 1.08 [95% confidence interval 1.04–1.12]) but this association was weaker compared to MI‐CAD (p interaction<.001). CONCLUSIONS: We found no evidence indicating the presence of a specific inflammatory pattern in acute MINOCA compared to MI‐CAD. However, CRP levels were independently, albeit moderately associated with adverse outcome.
format Online
Article
Text
id pubmed-8259160
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-82591602021-07-12 Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries Eggers, Kai M Baron, Tomasz Hjort, Marcus Nordenskjöld, Anna M Tornvall, Per Lindahl, Bertil Clin Cardiol Clinical Investigations BACKGROUND: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous condition. Recent studies suggest that MINOCA patients may have a proinflammatory disposition. The role of inflammation in MINOCA may thus be distinct to myocardial infarction with significant coronary artery disease (MI‐CAD). HYPOTHESIS: We hypothesized that inflammation reflected by C‐reactive protein (CRP) levels might carry unique clinical information in MINOCA. METHODS: This retrospective registry‐based cohort study (SWEDEHEART) included 9916 patients with MINOCA and 97 970 MI‐CAD patients, used for comparisons. Multivariable‐adjusted regressions were applied to investigate the associations of CRP levels with clinical variables, all‐cause mortality and major cardiovascular events (MACE) during a median follow‐up of up to 5.3 years. RESULTS: Median admission CRP levels in patients with MINOCA and MI‐CAD were 5.0 (interquartile range 2.0–9.0) mg/dl and 5.0 (interquartile range 2.1–10.0 mg/dl), respectively. CRP levels in MINOCA exhibited independent associations with various cardiovascular risk factors, comorbidities and estimates of myocardial damage. The association of CRP with peripheral artery disease tended to be stronger compared to MI‐CAD. The associations with female sex, renal dysfunction and myocardial damage were stronger in MI‐CAD. CRP independently predicted all‐cause mortality in MINOCA (hazard ratio 1.22 [95% confidence interval 1.17–1.26]), similar to MI‐CAD (p interaction = 0.904). CRP also predicted MACE (hazard ratio 1.08 [95% confidence interval 1.04–1.12]) but this association was weaker compared to MI‐CAD (p interaction<.001). CONCLUSIONS: We found no evidence indicating the presence of a specific inflammatory pattern in acute MINOCA compared to MI‐CAD. However, CRP levels were independently, albeit moderately associated with adverse outcome. Wiley Periodicals, Inc. 2021-05-25 /pmc/articles/PMC8259160/ /pubmed/34032303 http://dx.doi.org/10.1002/clc.23651 Text en © 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Eggers, Kai M
Baron, Tomasz
Hjort, Marcus
Nordenskjöld, Anna M
Tornvall, Per
Lindahl, Bertil
Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
title Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
title_full Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
title_fullStr Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
title_full_unstemmed Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
title_short Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
title_sort clinical and prognostic implications of c‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259160/
https://www.ncbi.nlm.nih.gov/pubmed/34032303
http://dx.doi.org/10.1002/clc.23651
work_keys_str_mv AT eggerskaim clinicalandprognosticimplicationsofcreactiveproteinlevelsinmyocardialinfarctionwithnonobstructivecoronaryarteries
AT barontomasz clinicalandprognosticimplicationsofcreactiveproteinlevelsinmyocardialinfarctionwithnonobstructivecoronaryarteries
AT hjortmarcus clinicalandprognosticimplicationsofcreactiveproteinlevelsinmyocardialinfarctionwithnonobstructivecoronaryarteries
AT nordenskjoldannam clinicalandprognosticimplicationsofcreactiveproteinlevelsinmyocardialinfarctionwithnonobstructivecoronaryarteries
AT tornvallper clinicalandprognosticimplicationsofcreactiveproteinlevelsinmyocardialinfarctionwithnonobstructivecoronaryarteries
AT lindahlbertil clinicalandprognosticimplicationsofcreactiveproteinlevelsinmyocardialinfarctionwithnonobstructivecoronaryarteries